We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Chromogenex | LSE:CGX | London | Ordinary Share | GB00B0B7XX32 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.325 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number : 9972Z
Chromogenex PLC
28 July 2008
Chromogenex plc
("Chromogenex" or "the Company")
Chromogenex Plc (AIM: CGX) an established manufacturer of cosmetic and medical laser and light based systems has today announced its
audited final results for the year ended 31 December 2007. Additionally it is announced that in accordance with the AIM Rules for Companies,
the audited accounts have been posted to shareholders and can be downloaded from the Company's website at www.chromogenex.com.
As trading in the Company's shares was suspended on 30 June 2008 pending the publication of these accounts, such suspension has now been
lifted with immediate effect.
For further information please see www.chromogenex.com or contact the following:
Chromogenex PLC Tel: +44 20 8434 0540
Peter McGuinness, Chairman
HB Corporate
Luke Cairns/Rory Creedon Tel: +44 (0)20 7510 8600
Threadneedle Communications
Graham Herring/Alex White Tel: +44 (0)20 7936 9605
This information is provided by RNS
The company news service from the London Stock Exchange
END
SRSEAEXPAADPEFE
1 Year Chromogenex Chart |
1 Month Chromogenex Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
